FBInvestor
Stocks / Sorrento Therapeutics Inc
Institutional Ownership

Sorrento Therapeutics Inc

CUSIP 83587F202COMMON STOCKSRNEQ1 2026

13D / 13G Filings
22
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
10.7%
Max % of class reported
Institutional Holders
4
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

22 filings · latest Mar 10, 2023

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Mar 10, 2023State Street Corp13G/A0.0%SEC
2Mar 8, 2023Blackrock Inc.13G/A75.7KSEC
3Feb 17, 2023Ics Opportunities, Ltd.13G2.4%11.38MSEC
4Feb 9, 2023Vanguard Group Inc13G/A6.3%29.54MSEC
5Feb 9, 2023State Street Corp13G/A10.7%SEC
6Feb 3, 2023Blackrock Inc.13G/A8.4%39.42MSEC
7Jul 11, 2022State Street Corp13G10.2%SEC
8Feb 10, 2022Vanguard Group Inc13G5.1%15.69MSEC
9Feb 7, 2022Blackrock Inc.13G/A6.9%21.78MSEC
10Feb 2, 2021Blackrock Inc.13G6.7%17.62MSEC

12 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Sorrento Therapeutics Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →